6-methyluracil has been researched along with Acute Confusional Senile Dementia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Gubaidullina, LM; Krylova, ES; Lenina, OA; Lushchekina, SV; Mukhamedyarov, MA; Petrov, KA; Petukhova, EO; Saifina, LF; Semenov, VE; Zueva, IV | 1 |
| Babaev, V; Dias, J; Ilyin, V; Lushchekina, S; Masson, P; Mukhamedyarov, M; Nachon, F; Nurullin, L; Pashirova, T; Petrov, K; Petrova, N; Semenov, V; Zakharova, L; Zueva, I | 1 |
| Kharlamova, AD; Lushchekina, SV; Masson, P; Mikhailov, AS; Minnekhanova, OA; Mukhamedyarov, MA; Nikolsky, EE; Petrov, KA; Petukhova, EO; Podyachev, SN; Reznik, VS; Saifina, LF; Semenov, VE; Zobov, VV; Zueva, IV | 1 |
3 other study(ies) available for 6-methyluracil and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Novel Acetylcholinesterase Inhibitors Based on Uracil Moiety for Possible Treatment of Alzheimer Disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Ammonium Compounds; Animals; Anions; Behavior, Animal; Binding Sites; Blood-Brain Barrier; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Disease Models, Animal; Drug Design; Drug Evaluation, Preclinical; Humans; Inhibitory Concentration 50; Maze Learning; Memory Disorders; Mice; Molecular Docking Simulation; Scopolamine; Uracil | 2020 |
New evidence for dual binding site inhibitors of acetylcholinesterase as improved drugs for treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Binding Sites; CHO Cells; Cholinesterase Inhibitors; Cricetinae; Cricetulus; Donepezil; Drug Development; Humans; Mice; Mice, Transgenic; Random Allocation; Treatment Outcome; Uracil | 2019 |
6-Methyluracil Derivatives as Bifunctional Acetylcholinesterase Inhibitors for the Treatment of Alzheimer's Disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Behavior, Animal; Brain; Cholinesterase Inhibitors; Crystallography, X-Ray; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Mice; Mice, Transgenic; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Uracil | 2015 |